Industry Payment Flow
Pharmaceutical & Medical Supplies payments
into Colombia.
If you are paying Colombian suppliers in this sector, the issue is rarely just the transfer itself. You need the beneficiary details, documents, value date, payment proof, and supplier communication to hold together when timing matters.
What usually creates pressure on this flow
Industry pressure
Regulatory shipments can't wait for your bank's settlement cycle.
- Strict regulatory compliance (MHRA, FDA)
- Temperature-controlled logistics
- High value, low volume shipments
- Payment timing critical for batch releases
Colombia payment reality
Your payment may need local beneficiary details, a clear purpose of payment, and documents that match the invoice and supplier name. If the receiving bank asks a question after funds are sent, the case becomes a release issue, not a generic transfer.
- Banco de la República de Colombia regulations
- DIAN (Tax Authority) documentation
- IVA (VAT 19%) on goods and services
- Customs declaration requirements
What better control looks like
Before you send
Confirm the beneficiary name, account details, invoice amount, currency, payment purpose, and any local routing detail before value leaves your account.
Where PSE (Pagos Seguros en Línea) or another local rail is available, the question is whether it fits your payment type, amount, and beneficiary setup.
After you send
You need payment proof the supplier can use, a clear reference trail, and a treasury contact who can help if the supplier says funds have not arrived or the bank asks for documents.
Details your team should get right
Supplier and beneficiary details
- Account Number: SWIFT/BIC and account number (no single national code)
- Coffee exporters (Eje Cafetero region)
- Flower growers (Bogotá savanna)
- Textile factories (Medellín, Bogotá)
- Emerald traders (Bogotá)
Documents and timing
- Payment upon batch release approval (not shipment). LC for first orders. Net 45-60 for established Indian generics suppliers.
- LC at sight for APIs over £100k. Net 45-60 for generics (India). Net 30 for EU medical devices. Escrow for clinical trial materials.
- Steady with flu season spikes (Oct-Mar). NHS contract cycles. Pandemic/epidemic surges unpredictable. Clinical trial timelines project-based.
- MODERATE: INR (generics), CHF (branded), EUR (devices). High margins (40-60%) on branded provide FX buffer. Generics (15-25%) more FX-sensitive.
- Certificate of Analysis (CoA)
- Certificate of Pharmaceutical Product (CPP)
- GDP Compliance Certificate
- Import License (MHRA)
- Colombia = Coffee leader (3rd globally), flower exporter (2nd globally)
- PSE widely adopted for COP payments
- Bogotá + Medellín + Cali = Main business centers
- Improving security situation - verify supplier locations
Need help with this trade payment?
If your supplier is waiting, your bank has asked for documents, or you need the payment flow checked before money moves, talk to us before it becomes a larger issue.